This is a no-brainer. Bacteria culture, especially with drug resistant strains like MRSA, should be conducted in a separate area than that in which cell/tissue culture takes place; however, I am having a very hard time tracking down something that says this in writing from NIH/CDC or WHO.
For perspective: Currently, the lab in question cultures are variety of tissue (BSL-2) as well as cells (MSCs), and a student is trying to introduce a MRSA project for biofilm applications. Can someone please provide me documentation outlining why this is dangerous for the biosecurity of the cell/tissue culture work currently ongoing in the culture room?
Any documentation outlining why bacteria and cell/tissue culture MUST be conducted in separate research spaces would be greatly appreciated. (Also, there is one biosafety cabinet, so this bacteria would be introduced into the singular culture room/hood and incubator system).